Drug profile · INN
interferon alfa-2a
ALPHEON
interferon alfa-2a (ALPHEON) is a interferon alpha/beta receptor agonist.
EMA: refused Antineoplastic and immunomodulating agents (L03) L03AB04
Patents linked 0
Pipeline programs 6
News articles 0
Drug details — interferon alfa-2a
- Class
- Antineoplastic and immunomodulating agents (L03)
- Route
- —
- Patents
- 0
- Programs
- 6
- Data quality
- 0.83
Quick answer
interferon alfa-2a (ALPHEON) is a interferon alpha/beta receptor agonist.
Key facts
INN interferon alfa-2a
Brand ALPHEON
Mechanism Interferon alpha/beta receptor agonist
Target Interferon alpha/beta receptor
Therapeutic class Antineoplastic and immunomodulating agents (L03)
ATC code L03AB04
Mechanism of action
Interferon alpha/beta receptor agonist
Primary target: Interferon alpha/beta receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | refused | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is interferon alfa-2a?
interferon alfa-2a (ALPHEON) is a interferon alpha/beta receptor agonist.
What is the brand name for interferon alfa-2a?
ALPHEON is a marketed brand name for interferon alfa-2a. Check FDA Drugs@FDA for the current US label holder and prescribing information.